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ABSTRACT Previous studies suggested that genetic factors exerted huge
influence in susceptibility to Tuberculosis. Tumor Necrosis
Factor Alpha (TNF-α), which is encoded by the TNF gene, play a
role on pulmonary macrophage function in isolating and
controlling Mycobacterium tuberculosis infection.
Polymorphisms on the promoter region of the TNF gene have
been predicted to affect its transcriptional activity. Therefore,
these polymorphisms are an excellent candidate to further study
the role of TNF-α in susceptibility to Tuberculosis. 100
pulmonary tuberculosis patients (case) and 100 healthy
individuals (controls) were recruited for this pilot study. DNA
samples from cases and controls were genotyped for the TNF -
238G>A SNP (rs361525) using LightSNip genotyping assay.
Our results showed no significant difference in the distribution
of TNF -238 genotypes in case and control subjects (P =
0.4335). Further investigation on TNF -238 allele frequencies
between case and control studies also yields no significant
difference (P=1.000; OR=1.000; %95CI [0.246597 – 4.055200])
which may suggest that there are no association with
predisposition to Tuberculosis infection. In conclusion, this pilot
study showed that the TNF -238G>A SNP is not associated
with susceptibility to Tuberculosis.
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BACKGROUND
Tuberculosis (TB) is a fatal but
curable disease, resulting from
pulmonary alveolar infection by
Mycobacterium tuberculosis (MTB).
Despite the implementation of the
DOTS (Directly Observed Treatment
Short-course) strategy since 1994,
Indonesia currently still has the fifth
largest TB incidence in the world
(WHO 2014). TB is known to be
contagious, and is still responsible for
high mortality worldwide (WHO 2014).
However, it is reported that only 10%
of people infected with MTB progress
to active TB disease (Bellamy 1998;
Kleinnijenhuis et al. 2011; Murray,
Styblo & Rouillon 1990).
Observations on this disease in
several human populations with
different race and ethnicities, showed
higher TB infection in certain
populations (Motulsky 1989; Stead et al.
1990). This suggests that genetic factors
played a role in susceptibility to TB
infection. Twin studies have also been
conducted, which further demonstrates
the genetic nature of susceptibility to
TB (Comstock 1978; Kallmann &
Reisner 1943). However, the exact
genetic factors or molecular
mechanisms involved, to date, remains
elusive.
Single nucleotide
polymorphisms (SNPs) are known to be
the most prevalent genetic variations
found among humans. Several
candidate genes which have known
biological function related to TB
infection in humans such as HLA
(Human Leucocyte Antigen), TLR (Toll-
like receptor), CD209 (C-type lectin DC-
SIGN) and IRF1 (Interferon Regulatory
Factor 1), have been investigated and
SNPs found in these genes showed
association with susceptibility or
protection to TB (Ding et al. 2012; Kim
et al. 2005; Kobayashi et al. 2012;
Vannberg et al. 2008). Many of the
genes found to significantly affect
susceptibility to TB played a role in
immune regulation pathways. Thus
host genetic factors, which participated
in the host immune response, are
excellent candidates to study and
further understand genetic
susceptibility to TB.
The pro-inflammatory cytokine
Tumor Necrosis Factor Alpha (TNF-α),
encoded by the TNF gene, is produced
mainly by macrophages and other
white blood cells derived from
monocytes. Mechanistic studies have
shown that TNF-α play a huge role in
MTB infection particularly in
macrophage activation, recruitment to
site of infection and granuloma
formation which contains and controls
the disease (Flesch & Kaufmann 1990;
Flynn et al. 1995; Lin et al. 2007; Mohan
et al. 2001). Moreover, a study in
rheumatoid arthritis patients treated
with the Anti-TNF drug Infliximab
showed that patients with latent TB
progress to active TB following
treatment with Infliximab (Keane et al.
2001).
Thus, it is postulated that the
regulation of TNF-α might affect
susceptibility to TB.  Single nucleotide
polymorphisms (SNP) found on the
promoter region of the TNF gene, such
as rs361525 (TNF -238) and rs1800629
(TNF -308), have been vastly studied
(Abraham & Kroeger 1999).
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Polymorphisms on promoter
region of the TNF gene were predicted
to influence its transcriptional activity
(Goldfeld, Doyle & Maniatis 1990). In
relation to TB susceptibility, TNF -238
polymorphism have been showed to
increase the risk of active TB
(Amirzargar et al. 2006; Correa et al.
2005; Oliveira et al. 2004).
Others have also reported that
polymorphisms in the promoter region
of TNF have been associated with
susceptibility or increased severity to
other infectious agents such as
Hepatitis B virus, A/H1N1 virus,
Malaria parasite and Helicobacter pylori
(Flori et al. 2005; Höhler et al. 1998;
Morales-Garcia et al. 2012; Yea et al.
2001). Therefore, we proposed that
certain TNF promoter genetic variants,
might affect susceptibility to TB,
specifically in the Indonesian
population. The study of disease
susceptibility genes will allow us to
understand better the infection
mechanism of TB which in turn will
allow us to devise a better strategy for
TB disease prevention and eradication.
METHODS
Study Participants
100 TB patients and 100 healthy
individual were recruited for the study.
All patients and controls are of
Indonesian background with Javanese
and Sundanese ethnicity, sex and age.
Active TB patients were confirmed by
Acid-Fast Bacilli smear test. All study
participants had signed an informed
consent form and this study was
approved by the Universitas YARSI
Research Ethics Committee.
SNP genotyping
DNA were extracted using the
QIAamp DNA blood mini kit (Qiagen,
Hilden, Germany) according to the
manufacturer’s instructions. Extracted
DNA were quantified using a Qubit 2.0
Fluorometer (Invitrogen, California,
USA) prior to SNP genotyping.
Genotyping of the TNF -238 SNP were
accomplished using LightSNiP
rs361525 TNF G-238A genotyping assay
based on the SimpleProbe probe
genotyping system (TIB MOLBIOL,
Berlin, Germany) on a LightCycler 480
II real-time PCR instrument (Roche
Applied Science, Mannheim,
Germany). Realtime PCR was
performed in a 5 μL reaction mixture
containing approximately 10 ng of
genomic DNA, 1X of 10X Lightcycler
FastStart DNA Master Hybprobe, 1X of
20X LightSNiP reagent mix (primers
and probes mix)  and  3 mM MgCl2,
using 384-well plates. The PCR
conditions are as follow: initial
denaturation at 96°C for 4 minutes; 40
cycles of denaturation at 96°C for 30
seconds, annealing at 55 °C for 30
seconds, and elongation at 72°C for 30
seconds; and a final elongation step at
72°C for 5 minutes.
Data Interpretation and Statistical
Analysis
Due to the unavailability of
control samples with known genotypes,
the LightSNip assay results,
particularly from control samples, were
calibrated with the genetic frequency of
rs361525 from public genetic
population data on dbSNP
(http://www.ncbi.nlm.nih.gov/project
s/SNP/snp_ref.cgi?rs=361525). This is
our method to define unknown
arbitrary genotypes used in the assay.
Χ2 test and Fisher exact test were used
to assess correlation between genotypes
or alleles and phenotypes of both cases
and controls, where appropriate. P
value of <0.05 was considered
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statistically significant. Odd ratios
estimate relative risk with 95%
confidence with. GraphPad Prism
Software version 5.06 (GraphPad, San
Diego, USA) was used for all statistical
calculations.
RESULTS
The LightSNip assay was
assessed by melting analysis which is
shown in figure 1. Each distinct melting
curve represents 1 sample and each
melting peaks represent different
alleles/genotypes.  As the required
known genotype controls were not
available, arbitrary genotypes AA, AB
and BB, were used to define the
homozygous and heterozygous melting
peaks. The genotype frequencies of for
the healthy controls are 96%, 4% and
0% for AA, AB and BB respectively.
According to the public SNP database
on TNF-238, G (Guanine) is the
frequent allele and A (Adenine) is the
rare allele, particularly in Asian
populations. Thus, we can assume that
the arbitrary genotypes AA, AB and BB
can be translated to GG, GA and AA
genotypes respectively.
As shown in Table 1, frequency
of the homozygous GG genotype was
relatively similar between TB patients
(cases) and healthy individuals
(controls) which were 97% and 96%
respectively. The heterozygous GA
genotype was present at 2% and 4% for
cases and controls respectively.
However, the homozygous AA
genotype was found only in TB
patients. Assessment of Hardy-
Weinberg Equilibrium showed that
population of the control group does
not deviate from Hardy-Weinberg
proportions (p=0.838298).
Statistical analysis between
genotype frequencies of cases and
controls showed no significant
differences between groups (P =
0.4335). TNF-238 allele frequencies
between cases and controls were shown
in Table 2. No significant differences in
allele frequencies were found between
case and control group (P=1.000;
OR=1.000; %95CI [0.246597 – 4.055200]).
The curve peaks at the left hand side
stand for the arbitrary A allele and at
the right hand side (red) stands for the
B allele. Single peaks represent
homozygotes (AA - Blue or BB - green)
while double peaks represent
heterozygotes (AB - red). Due to
unavailability of known genotype
controls, arbitrary genotypes were used
and correlation with public SNP
population database was utilized to
determine true genotypes.
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Figure 1. Melting analysis to determine TNF -238 genotypes in cases and controls.
Table 1. Genotype frequencies of the TNF -238 SNP between cases (TB patients) and
controls (Healthy individuals)
Genotype
TB
patients
[n (%)]
Controls
[n (%)]
GG 97 (97) 96 (96)
GA 2 (2) 4 (4)
AA 1 (1) 0 (0)
P = 0.4335
A B
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Table 2. Allele frequencies of the TNF -238 SNP between cases (TB patients) and
Controls (Healthy Individuals)
Allele
TB
patients
[n (%)]
Controls
[n (%)]
G 196(98) 196(98)
A 4(2) 4(2)
P=1.000; OR=1.000;
%95CI [0.246597 – 4.055200]
DISCUSSION
Our current data showed no
association between TNF -238 genotype
(P = 0.4335) and allele (P = 1.000)
variants with susceptibility to TB. Thus,
our study contradicts the reports by
Oliveira et al. in the Brazilian
population, Correa et al. in the
Northwestern Colombian (Spanish)
population and Amirzargar et al. in the
Iranian population at the same SNP
position (Amirzargar et al. 2006; Correa
et al. 2005; Oliveira et al. 2004). In spite
of these inconsistencies with the
previously mentioned studies, there
appears to be abundant reports which
suggests that TNF-238 alone does not
correlate well with increased risk of
susceptibility to TB (Anoosheh, Farnia
& Kargar 2011; Ates et al. 2008; Selvaraj
et al. 2001; Vejbaesya et al. 2007). TNF
promoter polymorphism was known to
be ethnic-specific (Baena et al. 2002). In
terms of ethnicity, the previous studies
by Anoosheh et al., Selvaraj et al. Ates et
al and Vejbaesya et al, were conducted
in the Iranian, Indian, Turkish and Thai
populations respectively. Therefore, the
positive studies by Amizargar et al.,
Oliveira et al. and Correa et al. may not
correspond well with our study, due to
differences in population genetic
backgrounds. The study by Vejbaesya
et al., which was done in the Thai
population, was presumed to be the
closest to us in terms of ethnicity and
genetic background (Hatin et al. 2014).
A study in The Cambodian
population showed that the TNF -238A
allele was quite rare in that specific
population, with frequency below 2%
in healthy individuals (Delgado et al.
2002). Our study showed that the A
allele was at most 2% in the population,
as shown in the controls, which was
consistent with the study in the
Cambodian population. Furthermore,
TNF -238A frequency in the Thai
population from the study by
Vejbaesya et al. was quite close (3.4%)
with the study in the Cambodian
population. On the other hand, the
study in the Colombian population
showed that the frequency of the TNF-
238A allele in healthy individuals was
much higher (11%) than both
Cambodia and Thailand (Henao et al.
2006). Therefore, these studies highlight
the differences in TNF promoter
polymorphisms frequencies between
populations, which further support the
result of this study.
The influence of TNF promoter
polymorphisms on transcriptional
activity of TNF polymorphism is
currently a controversial topic in the
field. There are 10 SNPs that have been
discovered in the promoter region of
the TNF-gene: -1031T>C, -863C>A, -
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857C>A, -851C>T, -419G>C, -376G>A, -
308G>A, -238G>A,-162G>A and -
49G>A. Several TNF promoter
polymorphisms have been studied
regarding their effect on TNF
transcriptional activity and gene
expression. Among those TNF
promoter polymorphisms, TNF -
308G>A is the most well studied
(Bayley, Ottenhoff & Verweij 2004). A
study by Wilson et al. in human B cell
line showed that the A allele of TNF -
308 had higher transcriptional activity
compared to the G allele (Wilson et al.
1994). Studies by Kroeger et al. and
Abraham et al. confirmed the previous
study, which showed that TNF -308
influenced TNF gene expression
(Abraham & Kroeger 1999; Kroeger,
Carville & Abraham 1997). However,
others have not been able to duplicate
the previous results (Brinkman et al.
1995; Knight et al. 2003; Mekinian et al.
2011).
On the other hand, several
studies investigating the functional
significance of TNF -238G>A have not
found concrete evidence related to
increased or decreased TNF promoter
transcriptional activity or gene
expression (Huizinga et al. 1997; Kaijzel
et al. 1998; Pociot et al. 1995; Uglialoro et
al. 1998). Nonetheless, several studies in
various infectious diseases have shown
the importance of TNF -238 G>A in
disease susceptibility, albeit with
currently unknown molecular
mechanism. In another study, Skoog et
al. showed evidence that TNF -863C>A
reduced TNF plasma levels and
transcriptional activity of TNF by 31%
(Skoog et al. 1999). Moreover, Higuchi
et al. also showed increased TNF
transcriptional activity in individuals of
Japanese descent with TNF -1031C and
-863A alleles (Higuchi et al. 1998).
However, no known study have shown
significant associations between these
SNPs with susceptibility to
Tuberculosis. Elahi et al. have
hypothesized that due to the
abundance of SNPs in the promoter
region of TNF, other SNPs in the
coding region of TNF might have
higher functional significance in
relation to TNF gene function (Elahi et
al. 2009). Therefore, a comprehensive
screen of all available SNPs on the TNF
gene needs to be investigated
thoroughly for future gene-disease
association studies particularly in the
study of Tuberculosis.
CONCLUSION
In conclusion, our pilot study
showed that the TNF -238 (rs361525) is
not associated with susceptibility to
Tuberculosis particularly in the
Indonesian population. Although
bigger sample size may help in
obtaining more reliable results,
screening of all SNPs in the TNF gene
or other TB susceptibility candidate
genes may be a better avenue for future
studies.
Limitations of this study
We currently do not supply a
known genotype control for the SNP
melting analysis, which may affect the
accuracy of the genotype calls.
Therefore, further assessment of the
genotype by sequencing is required to
confirm the different genotypes found.
Lastly, it is also essential to confirm
whether the differences in genotype,
affect the gene expression levels of
TNF, by monitoring the mRNA levels
of this gene initially in-vitro. Others
have also showed the limitations of
single SNP association study (reviewed
in (Bayley, Ottenhoff & Verweij 2004)),
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therefore we propose the inclusion of
all SNPs in the promoter and coding
region of TNF gene for further analysis,
and assess the association with
phenotype by haplotype
configurations.
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